394 results on '"Vandenbos, Fanny"'
Search Results
2. BRCA1/2 Pathogenic Variants Are Not Common in Merkel Cell Carcinoma: Comprehensive Molecular Study of 30 Cases and Meta-Analysis of the Literature
3. Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report
4. High-grade childhood intra-parenchymal brain tumor clustering with ATRT and expanding the cancer spectrum related to inherited SMARCE1 truncating variations
5. STRN::ALK, a novel fusion to foetal lung interstitial tumour
6. Glioblastoma cell motility depends on enhanced oxidative stress coupled with mobilization of a sulfurtransferase
7. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
8. A 78‐year‐old woman with diffuse white matter infiltration and predominant involvement of bilateral temporo‐parieto‐occipital regions
9. Primal-dual for classification with rejection (PD-CR): a novel method for classification and feature selection—an application in metabolomics studies
10. Analysis of a pituitary tumour with histological features of central neurocytoma points towards the emergence of a new entity recognizable by a specific epigenetic signature
11. Bevacizumab: Is the lower the better for glioblastoma patients in progression?
12. Is H3 K27M mutation testing relevant in the diagnostic routine of WHO grade 4 gliomas exclusively located in the corpus callosum in adults?
13. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults
14. 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions
15. An Atypical Heel Pain
16. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3
17. VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
18. Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
19. Urinary ketone body loss leads to degeneration of brain white matter in elderly SLC5A8-deficient mice
20. Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review
21. The molecular landscape of glioma in patients with Neurofibromatosis 1
22. Inactivation of Pif1 helicase causes a mitochondrial myopathy in mice
23. A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells
24. Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters. Author’s reply
25. Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection
26. Analysis of a pituitary tumour with histological features of central neurocytoma points towards the emergence of a new entity recognisable by a specific epigenetic signature.
27. Identification of Metabolomic Markers in Frozen or Formalin-Fixed and Paraffin-Embedded Samples of Diffuse Glioma from Adults.
28. Data from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells
29. Supplementary Data from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells
30. Supplementary tables S1-S3 from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells
31. figure legends and tables from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells
32. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas
33. The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review
34. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness
35. A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma
36. Adenomatoid Tumor of the Adrenal Gland: Differential Diagnosis Using Immunohistochemistry
37. Gliomes et mutations des gènes BRCA: association fortuite ou imputabilité?
38. Adequately defining tumor cell proportion in tissue samples for molecular testing improves interobserver reproducibility of its assessment
39. Autophagy inactivation in osteosarcoma leads to the appearance of poor prognosis-associated factors
40. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas
41. The human MSH5 (MutSHomolog 5) protein localizes to mitochondria and protects the mitochondrial genome from oxidative damage
42. Microfoci of malignant progression in diffuse low-grade gliomas: towards the creation of an intermediate grade in glioma classification?
43. Correction to: 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions
44. AGAP3: A novelBRAFfusion partner in pediatric pancreatic‐type acinar cell carcinoma
45. Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours
46. A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patient
47. Human glioblastoma cell motility depends on the activity of the cysteine metabolism enzyme 3‐Mercaptopyruvate sulfurtransferase
48. Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
49. Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report
50. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.